Semaglutide injection products, namely Novo Nordisks popular weight-loss drug Wegovy and its diabetes drug Ozempic, were first added to the FDAs drug shortages list in March 2022 and August 2022, respectively
Initial study results show that people lose a larger percentage of weight as much as 30% of their body weight when they take retatrutide compared with placebo
Fight inflammation Glutathione can help to combat inflammation, even chronic cases
While GLP-1 receptor agonists have a relatively wide safety margin, exceeding recommended doses or escalating too quickly can trigger severe adverse effects including acute pancreatitis, severe dehydration, and gastrointestinal damage
This dual effect helps lower blood glucose levels and improves insulin sensitivity
Lemaire V, Koehl M, Le Moal M, Abrous DN